Royalty Pharma
Logotype for Royalty Pharma plc

Royalty Pharma (RPRX) investor relations material

Royalty Pharma TD Cowen 46th Annual Health Care Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Royalty Pharma plc
TD Cowen 46th Annual Health Care Conference summary3 Mar, 2026

Strategic expansion and market opportunities

  • Announced hiring of Ken Xuan as Head of Asia to drive growth in China and Asia, leveraging his experience from Morgan Stanley.

  • Identified China as a significant future market for royalty deals, building on the first transaction with BeiGene and anticipating more opportunities.

  • Emphasized the explosion of licensing and partnership activity in Asia, viewing it as a greenfield opportunity for royalty creation.

Recent transactions and portfolio highlights

  • Closed a $250 million royalty deal with Zymeworks for zanidatamab, a HER2-positive gastric cancer therapy, securing 30% of global royalties.

  • Highlighted the $2 billion+ Revolution Medicines deal as a model for emerging biopharma, offering an alternative to traditional partnerships.

  • Noted a $1 billion royalty acquisition on Imdelltra, a lung cancer product, and a funding deal with Biogen for lupus R&D.

Capital deployment and financial outlook

  • Tracking ahead of five-year capital deployment goals, driven by the growing recognition of royalties as a funding source.

  • Projects annual capital deployment of $2–2.5 billion, with flexibility to adjust based on deal quality.

  • Maintains long-term revenue guidance of $4.7 billion by 2030, with about half of growth from existing assets and half from new investments.

  • Operates with 95% adjusted EBITDA margins and expects interest expense of $360–370 million, supporting strong cash flow and optionality for dividends and share repurchases.

China market development strategy
How does quality impact future deployment targets?
How does diversification mitigate LOE risk long-term?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Royalty Pharma earnings date

Logotype for Royalty Pharma plc
Q1 20267 May, 2026
Royalty Pharma
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Royalty Pharma earnings date

Logotype for Royalty Pharma plc
Q1 20267 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. The company's royalty acquisition segment engages in the acquisition of royalty streams from pharmaceutical companies. Its funding segment provides equity or loan financing to biotechnology companies developing innovative methods for the treatment of cancer, inflammatory disease, obesity, diabetes, and other metabolic disorders.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage